Dr. Sonya Abraham is a Consultant Research Physician specializing in rheumatology, general internal medicine, and early phase clinical studies. She was lead for clinical trials in inflammatory arthritis and north-west London CLRN Rheumatology lead. Nationally, she is the CCRN musculoskeletal industry liaison lead. Dr. Abraham's clinical and educational research interests include developing biomarkers in immune-mediated inflammatory disease, understanding the effects of steroids on intracellular pro-inflammatory signaling pathways, imaging in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis), and the impact of inflammatory disease on patients and their families. She holds a number of research grants related to these areas. Her PhD is from the Kennedy Institute of Rheumatology, where she examined the effect of glucocorticoids on pro-inflammatory intracellular signaling. Dr. Abraham is President of the Rheumatology and Rehabilitation section of the Royal Society of Medicine, chair of the British Psoriatic Arthritis Consortium, and north west London LCRN musculoskeletal and division 5 lead. She regularly lectures and has authored numerous clinical papers and book chapters on inflammation and rheumatology-related topics. Her clinical interests include rheumatology, arthritis, psoriatic arthritis, osteoarthritis, rheumatoid arthritis, inflammatory arthritis, and inflammatory joint disorders.